Skip to main content
    G

    Guardian Pharmacy Services, Inc. (GRDN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $49.42
    -0.09 (-0.19%)

    Market Cap: $3.14B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Guardian Pharmacy Services, Inc. (GRDN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Guardian Pharmacy Services reported revenue of $1.45B for the fiscal year ended Dec 31, 2025, up 17.9% from the year before. That year, net income was $48.96M with a net margin of 3.4%, operating cash flow was $100.25M and free cash flow was $67.29M. The quarter ended Sep 30, 2026 had revenue of $371.07M and net income of $19.12M.

    Revenue and Margins

    The operating margin was 5.0% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $600.37M, a compound annual rate of 13.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.45B+17.9%20.2%5.0%3.4%
    Dec 2024$1.23B+17.4%19.9%-5.1%-5.8%
    Dec 2023$1.05B+15.1%19.9%3.9%3.6%
    Dec 2022$908.91M+14.8%20.4%5.7%3.9%
    Dec 2021$792.07M+7.6%20.4%3.8%2.1%
    Dec 2020$735.96M+5.4%20.0%4.4%2.7%
    Dec 2019$698.29M+16.3%20.5%4.9%3.1%
    Dec 2018$600.37MN/A20.5%4.3%2.4%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 99.4% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$1.45B$1.23B$1.05B$908.91M$792.07M$735.96M$698.29M$600.37M
    Cost of revenue$1.16B$984.04M$837.88M$723.04M$630.81M$588.96M$554.83M$477.33M
    Gross profit$292.72M$244.37M$208.31M$185.87M$161.26M$147.00M$143.46M$123.03M
    Operating income$72.70M-$62.92M$40.95M$51.99M$30.15M$32.06M$34.10M$25.93M
    Net income$48.96M-$71.03M$37.72M$35.42M$16.31M$19.94M$21.75M$14.68M
    EBITDA$96.42M-$43.43M$58.81M$68.15M$46.49M$49.07M$49.47M$38.30M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$371.07M$351.77M$336.60M$397.62M$377.43M$344.33M$329.31M$338.57M$314.39M$300.04M$275.41M$281.07M
    Gross profit$85.22M$80.04M$76.31M$85.50M$74.72M$68.15M$64.35M$67.10M$60.88M$61.29M$55.10M$54.58M
    Operating income$25.06M$20.64M$17.68M$30.76M$16.35M$12.58M$13.01M$16.75M-$104.61M$17.00M$7.93M$15.52M
    Net income$19.12M$22.12M$13.54M$21.27M$9.59M$8.83M$9.27M$11.84M-$105.82M$15.85M$7.09M$12.02M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $7.15M by $58.47M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$412.66M$320.81M$271.17M$256.11M$235.85M$217.87M$196.51M$181.81M
    Current assets$221.63M$151.99M$129.60M$120.00M$111.87M$93.82M$90.08M$81.23M
    Cash and equivalents$65.62M$4.66M$752.00K$607.00K$15.01M$6.45M$275.00K$2.25M
    Total liabilities$194.73M$170.83M$211.31M$180.18M$182.53M$150.80M$139.47M$113.80M
    Short-term debt$7.15M$10.62M$12.98M$16.34M$11.93M$12.56M$19.87M$4.99M
    Long-term debtN/AN/A$18.99M$22.97M$26.99M$30.74MN/AN/A
    Shareholder equity$205.76M$142.67M$28.21M$42.73M$23.93M$38.48M$57.04M$34.03M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$491.78M$443.58M$426.94M$412.66M$390.04M$356.33M$334.00M$320.81M$348.03M$305.12MN/A$271.17M
    Total liabilities$212.06M$185.94M$194.52M$194.73M$194.54M$176.66M$170.78M$170.83M$214.13M$247.91M-$59.86M$211.31M
    Cash and equivalents$119.66M$89.81M$64.89M$65.62M$36.49M$18.82M$14.00M$4.66M$37.22M$1.54MN/A$752.00K
    Shareholder equity$267.24M$245.61M$220.89M$205.76M$183.76M$169.56M$156.09M$142.67M$127.57M$17.88M$59.86M$28.21M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 67.1% of operating cash flow. Dividends and share repurchases together came to 46.2% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$100.25M$57.96M$70.82M$48.52M$58.50M$52.61M$56.16M$43.67M
    Capital expenditures$32.96M$31.08M$15.54M$16.77M$9.28M$8.34M$14.54M$10.01M
    Free cash flow$67.29M$26.88M$55.28M$31.75M$49.22M$44.27M$41.62M$33.67M
    Dividends paid$458.00K$50.21M$54.90M$30.80M$17.36M$10.82M$34.32M$27.99M
    Share repurchases$30.63M$59.33M$0N/AN/AN/AN/AN/A
    Investing cash flow-$32.23M-$30.41M-$13.44M-$17.90M-$13.15M-$12.18M-$16.59M-$20.75M
    Financing cash flow-$7.07M-$23.64M-$57.23M-$45.03M-$36.79M-$34.26M-$41.55M-$21.07M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$43.37M$30.02M$6.06M$34.60M$28.17M$19.94M$17.55M$22.34M-$2.16M$29.13M$8.65M$14.55M
    Capital expenditures$8.43M$4.62M$5.02M$4.72M$3.71M$13.23M$5.80M$6.75M$7.34M$13.29M$3.69M$2.76M
    Free cash flow$34.94M$25.41M$1.04M$29.88M$24.46M$6.71M$11.74M$15.59M-$9.51M$15.84M$4.96M$11.79M
    Last 12 quarters

    Frequently Asked Questions About GRDN

    What is Guardian Pharmacy Services' annual revenue?

    Guardian Pharmacy Services reported revenue of $1.45B for the fiscal year ended Dec 31, 2025.

    How fast is Guardian Pharmacy Services' revenue growing?

    Revenue was up 17.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 16.8%.

    Is Guardian Pharmacy Services profitable?

    Yes. Guardian Pharmacy Services reported net income of $48.96M for the fiscal year ended Dec 31, 2025, with a net margin of 3.4%.

    How much free cash flow does GRDN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $100.25M minus capital expenditures of $32.96M produced free cash flow of $67.29M.

    How much debt does Guardian Pharmacy Services have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $7.15M and cash and equivalents of $65.62M.